Jci_page_head_homepage_01 Jci_page_head_homepage_02
Nico Scheer, Jillian Ross, Anja Rode, Branko Zevnik, Sandra Niehaves, Nicole Faust, C. Roland Wolf
Published in Volume 118, Issue 9
J Clin Invest. 2008; 118(9):3228–3239 doi:10.1172/JCI35483
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
Crosstalk between PXR and CAR.

A multitude of xenobiotics can interact with PXR or CAR or both. Ligand binding leads to the translocation of the receptor from the cytoplasm to the nucleus, where both PXR and CAR use the retinoic X receptor (RXR) as a partner for heterodimerization and bind to corresponding cis-acting elements of their target genes. PXR and CAR mediate gene regulation through certain direct repeats, known as the PXR responsive element (PXRRE) and the PB responsive element module (PBREM). Target genes that contain PXRREs and PBREMs in their promoters can be regulated both by PXR and CAR. Among those that are subject to PXR and CAR regulation are a number of genes encoding phase I or phase II drug-metabolizing enzymes or transporters. UGT, uridine diphosphate-glucuronosyltransferase; SULT, sulfotransferase; GST, glutathione S-transferase.